Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
Torres I, Bellido-Blasco JB, Gimeno C, Burgos JS, Albert E, Moya-Malo R, Gascó-Laborda JC, Tornero A, Soriano J, Meseguer-Ferrer N, Martínez-Serrano M, Ortíz-Rambla J, Buj H, Hernández N, Peiró S, Salas D, Limón R, Vanaclocha H, Sánchez-Payá J, Díez-Domingo J, Comas I, González-Candelas F, Navarro D; Valencian vaccine research program (ProVaVac) study group. Torres I, et al. Among authors: salas d. J Med Virol. 2022 Aug;94(8):3776-3782. doi: 10.1002/jmv.27799. Epub 2022 Apr 27. J Med Virol. 2022. PMID: 35445415 Free PMC article.
SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine.
Giménez E, Albert E, Burgos JS, Peiró S, Salas D, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Comas I, Gonzáles-Candelas F; Valencian vaccine research program (ProVaVac) study group. Giménez E, et al. Among authors: salas d. J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.02.035. Epub 2022 Mar 2. J Infect. 2022. PMID: 35245583 Free PMC article.
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine.
Giménez E, Albert E, Zulaica J, Torres I, Rusu L, Moreno AR, Burgos JS, Peiró S, Salas D, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Comas I, Gonzáles-Candelas F, Geller R, Navarro D; Valencian Vaccine Research Program (ProVaVac) Study Group. Giménez E, et al. Among authors: salas d. Clin Infect Dis. 2022 Aug 24;75(1):e865-e868. doi: 10.1093/cid/ciac223. Clin Infect Dis. 2022. PMID: 35314856 Free PMC article.
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents.
Albert E, Burgos JS, Peiró S, Salas D, Vanaclocha H, Giménez E, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Navarro D; Valencian Vaccine Research Programme (ProVaVac) Study Group. Albert E, et al. Among authors: salas d. Clin Microbiol Infect. 2022 Feb;28(2):279-284. doi: 10.1016/j.cmi.2021.09.031. Epub 2021 Oct 5. Clin Microbiol Infect. 2022. PMID: 34619398 Free PMC article.
Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain.
Sánchez-Saez F, Peiró S, Cuenca L, Vanaclocha H, Limón R, Salas D, Burgos JS, Sánchez-Payá J, Meneu R, Díez J, García-Sempere A, Navarro IH, Rodríguez-Bernal C, Sanfélix-Gimeno G, Navarro D; Valencian vaccine research program (ProVaVac) study group. Sánchez-Saez F, et al. Among authors: salas d. Vaccine. 2022 Sep 29;40(41):5942-5949. doi: 10.1016/j.vaccine.2022.08.028. Epub 2022 Aug 29. Vaccine. 2022. PMID: 36068110 Free PMC article.
Occupational Heat Exposure and Breast Cancer Risk in the MCC-Spain Study.
Hinchliffe A, Kogevinas M, Pérez-Gómez B, Ardanaz E, Amiano P, Marcos-Delgado A, Castaño-Vinyals G, Llorca J, Moreno V, Alguacil J, Fernandez-Tardón G, Salas D, Marcos-Gragera R, Aragonés N, Guevara M, Gil L, Martin V, Benavente Y, Gomez-Acebo I, Santibáñez M, Ángel Alba M, García AM, Pollán M, Turner MC. Hinchliffe A, et al. Among authors: salas d. Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):364-372. doi: 10.1158/1055-9965.EPI-20-0732. Epub 2020 Dec 2. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33268491 Free article.
Coffee consumption and colorectal cancer risk: a multicentre case-control study from Italy and Spain.
Rosato V, Guercio V, Bosetti C, Gracia-Lavedan E, Villanueva CM, Polesel J, Toffoluti F, Moreno V, Martin V, Aragonés N, Dierssen-Sotos T, Olmedo-Requena R, Guevara M, Amiano P, Salas D, Fernandez-Tardon G, Alguacil J, Chirlaque López MD, Fernandez-Villa T, Pérez-Gómez B, Gomez-Acebo I, Jiménez-Moleón JJ, Moreno-Iribas C, José Molina A, Castaño Vinyals G, Pollan M, Kogevinas M, La Vecchia C, Tavani A. Rosato V, et al. Among authors: salas d. Eur J Cancer Prev. 2021 May 1;30(3):204-210. doi: 10.1097/CEJ.0000000000000593. Eur J Cancer Prev. 2021. PMID: 33783378
Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study).
Hernández-García M, Molina-Barceló A, Vanaclocha-Espi M, Zurriaga Ó, Pérez-Gómez B, Aragonés N, Amiano P, Altzibar JM, Castaño-Vinyals G, Sala M, Ederra M, Martín V, Gómez-Acebo I, Vidal C, Tardón A, Marcos-Gragera R, Pollán M, Kogevinas M, Salas D. Hernández-García M, et al. Among authors: salas d. Cancer Causes Control. 2022 Jan;33(1):125-136. doi: 10.1007/s10552-021-01511-4. Epub 2021 Nov 24. Cancer Causes Control. 2022. PMID: 34817770 Free PMC article.
Risk factors for severe complications of colonoscopy in screening programs.
Vanaclocha-Espi M, Ibáñez J, Molina-Barceló A, Valverde-Roig MJ, Pérez E, Nolasco A, de la Vega M, de la Lastra-Bosch ID, Oceja ME, Espinàs JA, Font R, Pérez-Riquelme F, Arana-Arri E, Portillo I, Salas D; CRIBEA Group. Vanaclocha-Espi M, et al. Among authors: salas d. Prev Med. 2019 Jan;118:304-308. doi: 10.1016/j.ypmed.2018.11.010. Epub 2018 Nov 8. Prev Med. 2019. PMID: 30414944
Walking, biking or sport: how Spanish women attending breast cancer screening meet physical activity recommendations?
Peiró-Pérez R, Salas D, Vallés G, Abad-Fernandez MS, Vidal C, Sanchez-Contador Escudero C, Ascunce-Elizaga N, Zubizarreta R, Pedraz C, Pérez-Gómez B, Navarrete-Muñoz EM, Vioque J, Pollán M; DDM-Spain. Peiró-Pérez R, et al. Among authors: salas d. Eur J Public Health. 2015 Oct;25(5):857-63. doi: 10.1093/eurpub/cku248. Epub 2015 Mar 12. Eur J Public Health. 2015. PMID: 25767095
200 results